AstraZeneca Pharma India Ltd. (ASTRAZEN)
Market Closed
11 Aug, 22:00
MSE XNSE Primary MSE ₹
8,020. 85
-85.1
-1.0498%
₹
- Market Cap
- P/E Ratio
96% Div Yield
46 Volume
- Eps
₹ 8,105.95
Previous Close Want to track ASTRAZEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AstraZeneca Pharma India Ltd. (ASTRAZEN) Statistics
Valuation metrics
Market Cap -
Enterprise value 201.4B
Trailing P/E (ttm) 109.2
Forward P/E -
PEG ratio 1.76
Price/Sales (ttm) 9
Price/Book (mrq) 23.46
Enterprise Value/Revenue 8.85
Enterprise Value/EBITDA 70.6
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 389
Average volume (90 days) 448
Price summary
52-Week low 7,630
52-Week high 9,850
Beta -
50-Day moving average 8,184.65
200-Day moving average 8,420.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 36
Trailing annual dividend yield 0.0044%
5-Year annual dividend yield -
Payout ratio 0.43
Dividend Date 12 Sep 2025
Ex-Dividend Date 18 Jul 2025
Last split factor 5:1
Last split Date 15 Jun 2006
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.1%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 910.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 179.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 1.77%
Book value per share (mrq) 349.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
